Department of Ultrasound, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin 300000, China.
Department of Gynaecology and Obstetrics, Rizhao Hospital of TCM, Rizhao 276800, Shandong, China.
J Healthc Eng. 2022 Jan 25;2022:9707206. doi: 10.1155/2022/9707206. eCollection 2022.
Cervical cancer is the leading cause of cancer deaths among women, and more than 85% of cervical cancer deaths occur in low and middle-income countries. The purpose of this study is to investigate the functions of MAGI2-AS3 and miR-15b in cervical cancer.
The mRNA levels of MAGI2-AS3, miR-15b, and CCNE1 were evaluated using RT-qPCR assay. Dual-luciferase reporter gene assay was used to confirm whether miR-15b binds to CCNE1.
LncRNA MAGI2-AS3 was downregulated, while miR-15b was upregulated in cervical cancer. Cervical cancer patients with low expression of MAGI2-AS3 have a poor prognosis. Upregulation of MAGI2-AS3 inhibited proliferative and invasive abilities of HeLa cells via regulating the expression of miRNA-15b. MiR-15b inhibitor suppressed cell proliferation and invasion. CCNE1 was a direct target gene of miR-15b, which binds to the 3'-UTR of its mRNA. MiR-15b partially reversed the inhibitory effect of overexpression of MAGI2-AS3 on the proliferation and invasion of HeLa cells. MAGI2-AS3 mediated the expression of CCNE1 in HeLa cells.
LncRNA MAGI2-AS3 inhibits the proliferation and invasion of cervical cancer cells via the miRNA-15/CCNE1 axis. Our results illustrates that MAGI2-AS3 can be used as a useful clinical predictor for early diagnosis and prognosis assessment of cervical cancer.
宫颈癌是导致女性癌症死亡的主要原因,超过 85%的宫颈癌死亡发生在中低收入国家。本研究旨在探讨 MAGI2-AS3 和 miR-15b 在宫颈癌中的作用。
采用 RT-qPCR 法检测 MAGI2-AS3、miR-15b 和 CCNE1 的 mRNA 水平。双荧光素酶报告基因实验验证 miR-15b 是否与 CCNE1 结合。
在宫颈癌中,lncRNA MAGI2-AS3 表达下调,miR-15b 表达上调。MAGI2-AS3 低表达的宫颈癌患者预后不良。MAGI2-AS3 上调通过调节 miR-15b 的表达抑制 HeLa 细胞的增殖和侵袭能力。miR-15b 抑制剂抑制细胞增殖和侵袭。CCNE1 是 miR-15b 的直接靶基因,结合其 mRNA 的 3'-UTR。miR-15b 部分逆转了过表达 MAGI2-AS3 对 HeLa 细胞增殖和侵袭的抑制作用。MAGI2-AS3 在 HeLa 细胞中介导 CCNE1 的表达。
lncRNA MAGI2-AS3 通过 miR-15/CCNE1 轴抑制宫颈癌细胞的增殖和侵袭。我们的研究结果表明,MAGI2-AS3 可作为宫颈癌早期诊断和预后评估的有用临床预测因子。